rs7986369

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000643584.1(SUCLA2):​n.*214+16341G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.396 in 152,018 control chromosomes in the GnomAD database, including 12,516 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.40 ( 12516 hom., cov: 32)

Consequence

SUCLA2
ENST00000643584.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.00800

Publications

4 publications found
Variant links:
Genes affected
SUCLA2 (HGNC:11448): (succinate-CoA ligase ADP-forming subunit beta) Succinyl-CoA synthetase (SCS) is a mitochondrial matrix enzyme that acts as a heterodimer, being composed of an invariant alpha subunit and a substrate-specific beta subunit. The protein encoded by this gene is an ATP-specific SCS beta subunit that dimerizes with the SCS alpha subunit to form SCS-A, an essential component of the tricarboxylic acid cycle. SCS-A hydrolyzes ATP to convert succinate to succinyl-CoA. Defects in this gene are a cause of myopathic mitochondrial DNA depletion syndrome. A pseudogene of this gene has been found on chromosome 6. [provided by RefSeq, Jul 2008]
SUCLA2 Gene-Disease associations (from GenCC):
  • Leigh syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria
    Inheritance: AR, Mitochondrial Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000643584.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.502 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000643584.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SUCLA2
ENST00000643584.1
n.*214+16341G>T
intron
N/AENSP00000494987.1Q9P2R7-1
SUCLA2
ENST00000647008.1
n.1237+18030G>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.396
AC:
60199
AN:
151900
Hom.:
12512
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.508
Gnomad AMI
AF:
0.508
Gnomad AMR
AF:
0.287
Gnomad ASJ
AF:
0.366
Gnomad EAS
AF:
0.227
Gnomad SAS
AF:
0.276
Gnomad FIN
AF:
0.317
Gnomad MID
AF:
0.377
Gnomad NFE
AF:
0.387
Gnomad OTH
AF:
0.387
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.396
AC:
60228
AN:
152018
Hom.:
12516
Cov.:
32
AF XY:
0.386
AC XY:
28682
AN XY:
74294
show subpopulations
African (AFR)
AF:
0.508
AC:
21054
AN:
41454
American (AMR)
AF:
0.287
AC:
4377
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.366
AC:
1269
AN:
3470
East Asian (EAS)
AF:
0.227
AC:
1175
AN:
5172
South Asian (SAS)
AF:
0.277
AC:
1336
AN:
4822
European-Finnish (FIN)
AF:
0.317
AC:
3350
AN:
10560
Middle Eastern (MID)
AF:
0.367
AC:
108
AN:
294
European-Non Finnish (NFE)
AF:
0.387
AC:
26291
AN:
67956
Other (OTH)
AF:
0.383
AC:
807
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1833
3666
5500
7333
9166
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
566
1132
1698
2264
2830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.382
Hom.:
8560
Bravo
AF:
0.399
Asia WGS
AF:
0.254
AC:
884
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
2.3
DANN
Benign
0.59
PhyloP100
-0.0080

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs7986369;
hg19: chr13-48463123;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.